InsiderTrades

Form 4/A for BHVN Biohaven Ltd.

Accepted 2022-10-05 00:00:00 ET · period of report 2022-10-03 · accession 0001562180-22-007103 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MAI 2022-10-05 2022-10-03 BHVN Coric Vlad CEO, Dir J - Other $0.00 +415.4K 9,565 New $0
A 2022-10-05 2022-10-03 BHVN Coric Vlad CEO, Dir J - Other $0.00 +46.0K 622.3K +8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2022-10-03 J A 249,130 $0.00 249,130 I By: The Vladimir Coric Marital Trust — — (F1) Represents common shares of the Issuer ("Common Shares") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. ("RemainCo") to holders of its common shares (the "Distribution") pursuant to the Separation and Distribution Agreement (the "Separation Agreement"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. ("Pfizer"). (F2) This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired in the Distribution were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Common Shares acquired were indirectly held by the Reporting Person in the Vladimir Coric Family Trust, the Vladimir Coric Marital Trust, and the 401(K) Plan. There were no other changes made to the information in the Original Form 4. (F3) These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2 Common Common Shares 2022-10-03 J A 46,025 $0.00 622,284 D By: The Vladimir Coric Family Trust — — (F1) Represents common shares of the Issuer ("Common Shares") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. ("RemainCo") to holders of its common shares (the "Distribution") pursuant to the Separation and Distribution Agreement (the "Separation Agreement"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. ("Pfizer"). (F2) This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired in the Distribution were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Common Shares acquired were indirectly held by the Reporting Person in the Vladimir Coric Family Trust, the Vladimir Coric Marital Trust, and the 401(K) Plan. There were no other changes made to the information in the Original Form 4. (F3) These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3 Common Common Shares 2022-10-03 J A 156,750 $0.00 156,750 I By: 401(K) Plan — — (F1) Represents common shares of the Issuer ("Common Shares") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. ("RemainCo") to holders of its common shares (the "Distribution") pursuant to the Separation and Distribution Agreement (the "Separation Agreement"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. ("Pfizer"). (F2) This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired in the Distribution were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Common Shares acquired were indirectly held by the Reporting Person in the Vladimir Coric Family Trust, the Vladimir Coric Marital Trust, and the 401(K) Plan. There were no other changes made to the information in the Original Form 4.
4 Common Common Shares 2022-10-03 J A 9,565 $0.00 9,565 I — — (F1) Represents common shares of the Issuer ("Common Shares") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. ("RemainCo") to holders of its common shares (the "Distribution") pursuant to the Separation and Distribution Agreement (the "Separation Agreement"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. ("Pfizer"). (F2) This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the "Original Form 4"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired in the Distribution were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Common Shares acquired were indirectly held by the Reporting Person in the Vladimir Coric Family Trust, the Vladimir Coric Marital Trust, and the 401(K) Plan. There were no other changes made to the information in the Original Form 4.